| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0009 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |